Stockscreener 앱 받기
10.25
1.94%
0.18
전일 마감가:
$10.07
열려 있는:
$10.185
하루 거래량:
1.74M
Relative Volume:
0.93
시가총액:
$1.01B
수익:
-
순이익/손실:
$-44.84M
주가수익비율:
-21.81
EPS:
-0.47
순현금흐름:
$-44.23M
1주 성능:
-11.66%
1개월 성능:
-41.34%
6개월 성능:
-5.39%
1년 성능:
-9.64%
1일 변동 폭
$10.04
$10.46
1주일 범위
$9.97
$11.80
52주 변동 폭
$9.97
$18.90
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
명칭
Ars Pharmaceuticals Inc
전화
858-771-9307
주소
11682 EL CAMINO REAL, SUITE 120, SAN DIEGO
SPRY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SPRY
Ars Pharmaceuticals Inc
|
10.25 | 995.18M | 0 | -44.84M | -44.23M | -0.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.51 | 101.56B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.19 | 59.25B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.26 | 60.77B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
761.70 | 45.95B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.23 | 37.61B | 3.81B | -644.79M | -669.77M | -6.24 |
Ars Pharmaceuticals Inc Stock (SPRY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | Roth Capital | Buy |
| 2025-03-07 | 개시 | Scotiabank | Sector Outperform |
| 2025-02-10 | 개시 | Oppenheimer | Outperform |
| 2024-08-20 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-08-12 | 재확인 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | Raymond James | Outperform |
| 2024-03-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-02-20 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-09-20 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Wedbush | Outperform |
| 2023-01-03 | 개시 | William Blair | Outperform |
| 2022-12-13 | 개시 | SVB Leerink | Outperform |
모두보기
Ars Pharmaceuticals Inc 주식(SPRY)의 최신 뉴스
Real-World Evidence Supports Clinical Effectiveness of - GlobeNewswire
89% Success Rate: Revolutionary Nasal Spray neffy Matches Standard Injection for Life-Threatening Allergies - Stock Titan
Published on: 2025-09-08 12:54:11 - beatles.ru
Ars Pharmaceuticals Reports Strong Q2 Growth and Global Expansion - MSN
ARS Pharmaceuticals (SPRY) Faces Patent Test as Lupin Files ANDA - MSN
What moving averages say about ARS Pharmaceuticals Inc.Weekly Stock Report & Consistent Return Investment Signals - Newser
Will ARS Pharmaceuticals' (SPRY) Conference Outreach Shape Investor Expectations for neffy's Global Potential? - simplywall.st
Is it too late to sell ARS Pharmaceuticals Inc.July 2025 PostEarnings & AI Driven Stock Price Forecasts - Newser
What’s the outlook for ARS Pharmaceuticals Inc.’s sectorQuarterly Market Review & Risk Controlled Stock Pick Alerts - خودرو بانک
Using economic indicators to assess ARS Pharmaceuticals Inc. potentialJuly 2025 Levels & Real-Time Stock Entry Alerts - Newser
ARS Pharmaceuticals stock hits 52-week low at 9.97 USD By Investing.com - Investing.com Canada
What is ARS Pharmaceuticals Inc. s debt to equity ratio2025 Sector Review & Growth Focused Investment Plans - خودرو بانک
What drives ARS Pharmaceuticals Inc.’s stock priceTrade Performance Summary & Reliable Price Breakout Signals - خودرو بانک
Key resistance and support levels for ARS Pharmaceuticals Inc.Earnings Growth Summary & Safe Entry Trade Signal Reports - Newser
Price momentum metrics for ARS Pharmaceuticals Inc. explainedJuly 2025 Setups & Expert Curated Trade Setups - Newser
ARS Pharmaceuticals stock hits 52-week low at 9.97 USD - Investing.com
Is ARS Pharmaceuticals Inc. backed by strong institutional buyingEarnings Recap Summary & Daily Technical Stock Forecast Reports - خودرو بانک
Analysts Offer Insights on Healthcare Companies: Novan (NOVN) and ARS Pharmaceuticals (SPRY) - The Globe and Mail
Intraday pattern recognizer results for ARS Pharmaceuticals Inc.2025 Trade Ideas & Real-Time Stock Price Movement Reports - Newser
Chart overlay techniques for tracking ARS Pharmaceuticals Inc.Global Markets & Real-Time Buy Zone Alerts - Newser
Comparing ARS Pharmaceuticals Inc. in custom built stock radarsMarket Risk Report & Risk Managed Investment Strategies - Newser
When is the best time to exit ARS Pharmaceuticals Inc.Portfolio Update Report & Stepwise Entry/Exit Trade Alerts - Newser
Is ARS Pharmaceuticals Inc. forming a bottoming basePortfolio Value Summary & Daily Entry Point Alerts - Newser
What recovery options are there for ARS Pharmaceuticals Inc.Trade Performance Summary & Community Verified Watchlist Alerts - Newser
What are the risks of holding ARS Pharmaceuticals Inc.2025 Bull vs Bear & Free Accurate Trade Setup Notifications - خودرو بانک
What are ARS Pharmaceuticals Inc.’s earnings expectationsJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - خودرو بانک
Roth/MKM initiates ARS Pharmaceuticals stock with Buy rating on neffy potential - Investing.com
What are ARS Pharmaceuticals Inc.’s growth leversJuly 2025 Snapshot & Verified Momentum Stock Watchlist - خودرو بانک
Short Squeeze: How does ARS Pharmaceuticals Inc. compare to its peersWeekly Trade Summary & Breakout Confirmation Trade Signals - خودرو بانک
ARS Pharmaceuticals, Inc.'s (NASDAQ:SPRY) 27% Share Price Plunge Could Signal Some Risk - 富途牛牛
What machine learning models say about ARS Pharmaceuticals Inc.July 2025 Movers & Safe Capital Investment Plans - Newser
Using data models to predict ARS Pharmaceuticals Inc. stock movementGap Up & Community Shared Stock Ideas - Newser
Applying Elliott Wave Theory to ARS Pharmaceuticals Inc.Rate Hike & Breakout Confirmation Alerts - Newser
Real time social sentiment graph for ARS Pharmaceuticals Inc.Trend Reversal & Trade Opportunity Analysis - Newser
Can ARS Pharmaceuticals Inc. scale operations efficientlyEarnings Beat & AI Powered Market Entry Strategies - خودرو بانک
Can ARS Pharmaceuticals Inc. be the next market leaderJuly 2025 Volume & Momentum Based Trading Ideas - خودرو بانک
How volatile is ARS Pharmaceuticals Inc. stockJuly 2025 Rallies & Risk Controlled Stock Alerts - خودرو بانک
Real time pattern detection on ARS Pharmaceuticals Inc. stockJuly 2025 Price Swings & High Accuracy Buy Signal Tips - Newser
Can ARS Pharmaceuticals Inc. rally from current levelsMarket Activity Report & Low Risk Growth Stock Ideas - Newser
Risk vs reward if holding onto ARS Pharmaceuticals Inc.2025 Trading Recap & Intraday High Probability Alerts - Newser
ARS Pharmaceuticals Inc. recovery potential after sell off2025 Market Sentiment & Free Real-Time Market Sentiment Alerts - Newser
Will ARS Pharmaceuticals Inc. benefit from seasonalityMarket Performance Report & Low Drawdown Momentum Ideas - خودرو بانک
Insider Sell: Is ARS Pharmaceuticals Inc. stock a hidden gemQuarterly Portfolio Summary & Scalable Portfolio Growth Methods - خودرو بانک
Can ARS Pharmaceuticals Inc. deliver consistent dividendsJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - خودرو بانک
Is ARS Pharmaceuticals Inc. stock trending bullishJuly 2025 Final Week & Free Real-Time Market Sentiment Alerts - خودرو بانک
Is ARS Pharmaceuticals Inc. stock a falling knife or bargain buy2025 Price Momentum & Free Expert Verified Stock Movement Alerts - خودرو بانک
How does ARS Pharmaceuticals Inc. compare to its peersBull Run & Expert Approved Momentum Trade Ideas - خودرو بانک
Custom watchlist performance reports with ARS Pharmaceuticals Inc.2025 Technical Overview & Expert Verified Stock Movement Alerts - Newser
Using flow based indicators on ARS Pharmaceuticals Inc.2025 Momentum Check & Expert Verified Movement Alerts - Newser
Ars Pharmaceuticals Inc (SPRY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
14.24%
0.06%
자본화:
|
볼륨(24시간):